Literature DB >> 22290949

Nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Klebsiella oxytoca in Austria.

Martin Hoenigl1, Thomas Valentin, Gernot Zarfel, Benjamin Wuerstl, Eva Leitner, Helmut J F Salzer, Josefa Posch, Robert Krause, Andrea J Grisold.   

Abstract

To date, no outbreak of carbapenemase-producing bacteria has been reported for Austria. While outbreaks of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae have been increasingly reported, no outbreak caused by KPC-producing Klebsiella oxytoca has been described yet, to the best of our knowledge. We report an outbreak of KPC-producing K. oxytoca. In 5 months, 31 KPC-producing Klebsiella oxytoca strains were isolated from five patients. All patients were admitted to the same medical intensive care unit in Austria.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22290949      PMCID： PMC3318378          DOI： 10.1128/AAC.05440-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  28 in total

1.  Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Authors:  Neil Woodford; Philip M Tierno; Katherine Young; Luke Tysall; Marie-France I Palepou; Elaina Ward; Ronald E Painter; Deborah F Suber; Daniel Shungu; Lynn L Silver; Kenneth Inglima; John Kornblum; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.

Authors:  Shiri Navon-Venezia; Azita Leavitt; Mitchell J Schwaber; J Kamile Rasheed; Arjun Srinivasan; Jean B Patel; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

Review 3.  The international sepsis forum consensus conference on definitions of infection in the intensive care unit.

Authors:  Thierry Calandra; Jonathan Cohen
Journal:  Crit Care Med       Date:  2005-07       Impact factor: 7.598

4.  A cluster of nosocomial Klebsiella oxytoca bloodstream infections in a university hospital.

Authors:  Yesim Cetinkaya Sardan; Pinar Zarakolu; Belgin Altun; Aycan Yildirim; Gonul Yildirim; Gulsen Hascelik; Omrum Uzun
Journal:  Infect Control Hosp Epidemiol       Date:  2004-10       Impact factor: 3.254

5.  Outbreak of Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae with high qnr prevalence in a Chinese hospital.

Authors:  Rong Zhang; Xuan Ding Wang; Jia Chang Cai; Hong Wei Zhou; Huo Xiang Lv; Qing Feng Hu; Gong-Xiang Chen
Journal:  J Med Microbiol       Date:  2011-03-10       Impact factor: 2.472

6.  Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.

Authors:  J Kamile Rasheed; James W Biddle; Karen F Anderson; Laraine Washer; Carol Chenoweth; John Perrin; Duane W Newton; Jean B Patel
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

7.  Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.

Authors:  Gopi Patel; Shirish Huprikar; Stephanie H Factor; Stephen G Jenkins; David P Calfee
Journal:  Infect Control Hosp Epidemiol       Date:  2008-12       Impact factor: 3.254

8.  Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.

Authors:  Abhijeet S Nadkarni; Tjark Schliep; Lamia Khan; Cosmina B Zeana
Journal:  Am J Infect Control       Date:  2009-03       Impact factor: 2.918

9.  Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

Authors:  Mitchell J Schwaber; Shiri Klarfeld-Lidji; Shiri Navon-Venezia; David Schwartz; Azita Leavitt; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

10.  KPC type beta-lactamase, rural Pennsylvania.

Authors:  Jonathan Pope; Jennifer Adams; Yohei Doi; Dora Szabo; David L Paterson
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883
View more
  8 in total

1.  Complete genome sequence of Klebsiella oxytoca E718, a New Delhi metallo-β-lactamase-1-producing nosocomial strain.

Authors:  Tsai-Lien Liao; Ann-Chi Lin; Elsa Chen; Tzu-Wen Huang; Yen-Ming Liu; Ya-Hui Chang; Jui-Fen Lai; Tsai-Ling Lauderdale; Jann-Tay Wang; Shan-Chwen Chang; Shih-Feng Tsai; Ying-Tsong Chen
Journal:  J Bacteriol       Date:  2012-10       Impact factor: 3.490

2.  Contaminated handwashing sinks as the source of a clonal outbreak of KPC-2-producing Klebsiella oxytoca on a hematology ward.

Authors:  Eva Leitner; Gernot Zarfel; Josefa Luxner; Kathrin Herzog; Shiva Pekard-Amenitsch; Martin Hoenigl; Thomas Valentin; Gebhard Feierl; Andrea J Grisold; Christoph Högenauer; Heinz Sill; Robert Krause; Ines Zollner-Schwetz
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

3.  Klebsiella oxytoca: An emerging pathogen?

Authors:  Lavan Singh; M P Cariappa; Mandeep Kaur
Journal:  Med J Armed Forces India       Date:  2016-06-14

4.  Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.

Authors:  Jing Yang; Haiyan Long; Ya Hu; Yu Feng; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2021-12-01       Impact factor: 50.129

5.  First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela.

Authors:  Indira Labrador; María Araque
Journal:  Case Rep Infect Dis       Date:  2014-10-22

6.  Identification of Klebsiella pneumoniae Carbapenemase-producing Klebsiella oxytoca in Clinical Isolates in Tehran Hospitals, Iran by Chromogenic Medium and Molecular Methods.

Authors:  Majid Validi; Mohammad Mehdi Soltan Dallal; Masoumeh Douraghi; Jalil Fallah Mehrabadi; Abbas Rahimi Foroushani
Journal:  Osong Public Health Res Perspect       Date:  2016-08-31

7.  Exploring the Global Spread of Klebsiella grimontii Isolates Possessing blaVIM-1 and mcr-9.

Authors:  Edgar I Campos-Madueno; Aline I Moser; Martin Risch; Thomas Bodmer; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

8.  Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.

Authors:  Ai Fujita; Kouji Kimura; Satoru Yokoyama; Wanchun Jin; Jun-Ichi Wachino; Keiko Yamada; Hiroyuki Suematsu; Yuka Yamagishi; Hiroshige Mikamo; Yoshichika Arakawa
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.